Polmed S.A. has announced the acquisition of 100% of shares in Kliniki Neuroradiochirurgii, facilitated by CIC Corporate Finance, pending regulatory approval.

Target Information

CIC Corporate Finance served as the exclusive transaction advisor to Polmed S.A. in its acquisition of 100% of shares in Kliniki Neuroradiochirurgii. The completion of this transaction is contingent upon obtaining the necessary approval from the Office of Competition and Consumer Protection (UOKiK) and meeting specific conditions precedent.

Since its inception in 1999, Polmed S.A. has diligently expanded both its scale and the breadth of services it offers. By 2024, the Group achieved revenues exceeding €100 million. It now provides a comprehensive range of medical care that includes outpatient services, diagnostic imaging, as well as home and inpatient rehabilitation. Polmed collaborates with over 4,000 medical partners and employs 2,000 specialists, delivering care to more than 4 million patients annually, including upwards of 3,500 corporate clients.

Industry Overview in Poland

The healthcare sector in Poland has been witnessing considerable growth due to an aging population and increasing demand for specialized medical services. The private healthcare market, in particular, has expanded rapidly as pa